Reconfigurable Multi-Organ-on-a-Chip System Reliably Evaluates Chemotherapy Toxicity (3 of 5) (IMAGE)

American Association for the Advancement of Science (AAAS)

Reconfigurable Multi-Organ-on-a-Chip System Reliably Evaluates Chemotherapy Toxicity (3 of 5)

Caption

Hesperos's reconfigurable human-based body-on-a-chip system mimics the way human organs interact with each other and respond to drug testing. This material relates to a paper that appeared in the Jun. 19, 2019, issue of Science Translational Medicine, published by AAAS. The paper, by C.W. McAleer at Hesperos Inc. in Orlando, FL; and colleagues was titled, "Multi-organ system for the evaluation of efficacy and off-target toxicity of anticancer therapeutics."

Credit

Hesperos

Usage Restrictions

Please cite the owner of the material when publishing. This material may be freely used by reporters as part of news coverage, with proper attribution. Non-reporters must contact <i>Science</i> for permission.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.